Autonomous Airway Management System
Legal Citation
Summary of the Inventive Concept
A self-sustaining, autonomous airway management system integrating AI-powered predictive analytics, modular airway devices, and real-time data-driven decision-making to optimize patient safety and minimize medical professional exposure.
Background and Problem Solved
The original supraglottic airway device patent addressed contamination exposure risks, but the next generation of airway management requires more proactive, data-driven, and autonomous solutions to ensure optimal patient care and safety. The new inventive concept tackles the limitations of traditional airway devices by introducing AI-driven predictive analytics, real-time monitoring, and adaptive airway management.
Detailed Description of the Inventive Concept
The autonomous airway management system comprises a neural network-based predictive analytics module that detects patient respiratory distress and a dynamically adjustable, modular airway device responding to the predictive analytics module. The system integrates a cloud-based, machine learning-powered analytics platform, providing medical professionals with real-time, personalized recommendations for optimizing patient airway safety and minimizing exposure to patient discharge. The system also includes a sensor-equipped supraglottic airway device monitoring patient vital signs and airway parameters in real-time, with a decentralized, blockchain-based data storage module for securely storing and sharing patient data.
Novelty and Inventive Step
The new inventive concept introduces a paradigm shift in airway management by integrating AI-driven predictive analytics, real-time monitoring, and adaptive airway management, which is not anticipated by the original patent. The novel combination of these elements provides a self-sustaining, autonomous airway management system that optimizes patient safety and minimizes medical professional exposure.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include wearable, implantable, or injectable airway monitoring devices, virtual or augmented reality-based airway simulation platforms, and decentralized, blockchain-based data storage modules. Variations could also include integrating the system with existing electronic health records, hospital information systems, or telemedicine platforms.
Potential Commercial Applications and Market
The autonomous airway management system has significant commercial potential in the healthcare industry, particularly in hospitals, clinics, and ambulatory care settings. The system could be marketed as a comprehensive airway management solution, offering improved patient safety, reduced medical professional exposure, and enhanced data-driven decision-making capabilities.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M16/0409 |
| A | A61 | A61M16/0445 |
| A | A61 | A61M16/0463 |
| A | A61 | A61M16/0816 |
| A | A61 | A61M16/0833 |
| A | A61 | A61M16/0858 |
| A | A61 | A61M16/105 |
| A | A61 | A61M39/06 |
| A | A61 | A61M16/0434 |
| A | A61 | A61M16/0683 |
| A | A61 | A61M16/1055 |
| A | A61 | A61M2205/583 |
Original Patent Information
| Patent Number | US 11,857,709 |
|---|---|
| Title | Supraglottic airway device |